Cargando…
Autologous Graft-Versus-Host Disease of the Gastrointestinal Tract in Patients With Multiple Myeloma and Hematopoietic Stem Cell Transplantation
Multiple myeloma (MM) is the most common indication for autologous hematopoietic stem cell transplantation (HSCT) in North America. Despite occurring in up to 50% of patients undergoing allogeneic HSCT, the incidence of graft-versus-host disease (GVHD) after autologous HSCT is reportedly only 5-20%....
Autores principales: | Hammami, Muhammad B., Talkin, Rebecca, Al-Taee, Ahmad M., Schoen, Martin W., Goyal, Sagun D., Lai, Jin-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827903/ https://www.ncbi.nlm.nih.gov/pubmed/29511407 http://dx.doi.org/10.14740/gr925w |
Ejemplares similares
-
Graft-Versus-Host Disease of the Upper Gastrointestinal Tract After an Autologous Stem Cell Transplant
por: Barbash, Benjamin, et al.
Publicado: (2014) -
Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
por: Choi, Sue In, et al.
Publicado: (2016) -
Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?
por: Abudayyeh, Ala, et al.
Publicado: (2015) -
Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma
por: Lee, Sung-Eun, et al.
Publicado: (2013) -
Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)